ZLAB · Healthcare · $3.0B
$26.34+1.58%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“제품 매출이 1억 달러로 떨어졌던 전 분기에서 1억580만 달러로 11% 반등했지만, 지난해 4분기 1억2800만 달러에는 아직 못 미쳐 완전한”
In the company's words · 2026 2분기 earnings call